Bristol Myers Squibb Presents Positive Late-Breaking Data from Phase 3 True North Trial Evaluating Zeposia in Adult Patients with Moderate to Severe Ulcerative Colitis Biotech Investing
Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting Biotech Investing
Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, PhD to its Medical and Scientific Advisory Board Biotech Investing
Final Results of National Institute of Allergy and Infectious Diseases' ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® for the Treatment of COVID-19 Biotech Investing
Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure Biotech Investing
Gilead Sciences Signs Joint Procurement Agreement With the European Commission for Veklury® Biotech Investing
Naturally Splendid CEO: Our Focus on Plant-based Nutrition is Our Competitive Advantage Video Interview
Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business Biotech Investing
Health Canada Approves ZEPOSIA®, an Oral Treatment for Relapsing Remitting Multiple Sclerosis Biotech Investing
Opdivo Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Biotech Investing
